PTCT

PTCT Operating Expenses

$712.31MTTM · USD

Period ending:

PTCT FY Operating ExpensesUSD
PTCT FY Operating Expenses2011-12-31: $68.38M2012-12-31: $55.59M2013-12-31: $76.72M2014-12-31: $122.38M2015-12-31: $203.90M2016-12-31: $214.76M2017-12-31: $254.11M2018-12-31: $348.41M2019-12-31: $536.00M2020-12-31: $793.59M2021-12-31: $880.71M2022-12-31: $1.10B2023-12-31: $1.31B2024-12-31: $1.05B2025-12-31: $802.39M$1.31B$0.00
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PTCT operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Ptc Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
802,392,000
1,051,952,000
1,311,838,000
1,101,532,000
880,708,000
793,592,000
536,003,000
348,409,000
254,107,000
214,763,000
203,896,000
122,376,000
76,723,586
55,587,259
68,378,854

Compare operating expenses

All PTCT financial metrics · PTCT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.